Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-11

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament.

This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy

NCT05100355

Catheter Dysfunction

COMPLETED NA

Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients

NCT05966909

Catheter Related Complication

COMPLETED

The Side of Implantable Central Vascular Catheters and Complications

NCT01525277

Upper Extremity Deep Vein Thrombosis, Secondary

UNKNOWN

Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients

NCT01661218

Thrombosis Infections

COMPLETED

Evaluation of the Occurrence of Acute Complications Caused by a Central Venous Catheter Placement

NCT01405534

Anesthesia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Venous Catheter Thrombosis Central Venous Catheter Related Bloodstream Infection Solid Tumor Hematologic Malignancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

central venous catheter

collection and descriptionof central venous catheter-related complications

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients older than 18 years, with solid cancer or hematological malignancy receiving anticancer treatment in the outpatient medical department of Alpes Leman Hospital and having a central venous catheter been placed between the 11th of July 2022, and the 1st of January 2023.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No